↓ Skip to main content

Biopharmaceuticals, an Industrial Perspective

Overview of attention for book
Cover of 'Biopharmaceuticals, an Industrial Perspective'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Biopharmaceuticals, an overview
  3. Altmetric Badge
    Chapter 2 Abciximab: The First Platelet Glycoprotein IIb/IIIa Receptor Antagonist
  4. Altmetric Badge
    Chapter 3 Recombinant Coagulation Factor IX (BeneFIX®)
  5. Altmetric Badge
    Chapter 4 Biopharmaceutical Drug Development: A Case History
  6. Altmetric Badge
    Chapter 5 Follitropin beta (Puregon)
  7. Altmetric Badge
    Chapter 6 Insulin Lispro (Humalog)
  8. Altmetric Badge
    Chapter 7 Interferon beta-1b — the first long-term effective treatment of relapsing-remitting and secondary progressive multiple sclerosis (MS)
  9. Altmetric Badge
    Chapter 8 Reteplase, a recombinant plasminogen activator
  10. Altmetric Badge
    Chapter 9 Stabilisation of biopharmaceutical products and finished product formulations
  11. Altmetric Badge
    Chapter 10 Patent Law for Biopharmaceuticals
  12. Altmetric Badge
    Chapter 11 The development of new medicines: an overview
  13. Altmetric Badge
    Chapter 12 The EMEA and regulatory control of (bio)pharmaceuticals within the European Union
  14. Altmetric Badge
    Chapter 13 Biopharmaceutical Validation: an overview
  15. Altmetric Badge
    Chapter 14 Validation of Biopharmaceutical Chromatography Systems
  16. Altmetric Badge
    Chapter 15 Validation of Water for Injections (WFI) for Biopharmaceutical Manufacture
  17. Altmetric Badge
    Chapter 16 Information retrieval and the biopharmaceutical industry: an introductory overview
  18. Altmetric Badge
    Chapter 17 Information technology and the internet as a resource of biopharmaceutical information
  19. Altmetric Badge
    Chapter 18 Marketing Issues for the (Bio)pharmaceutical sector
  20. Altmetric Badge
    Chapter 19 Viral mediated gene therapy
  21. Altmetric Badge
    Chapter 20 Pharmaceutical gene medicines for non-viral gene therapy
Attention for Chapter 7: Interferon beta-1b — the first long-term effective treatment of relapsing-remitting and secondary progressive multiple sclerosis (MS)
Altmetric Badge

Citations

dimensions_citation
15 Dimensions
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Interferon beta-1b — the first long-term effective treatment of relapsing-remitting and secondary progressive multiple sclerosis (MS)
Chapter number 7
Book title
Biopharmaceuticals, an Industrial Perspective
Published by
Springer, Dordrecht, January 1999
DOI 10.1007/978-94-017-0926-2_7
Book ISBNs
978-9-04-815237-7, 978-9-40-170926-2
Authors

R. Horowski, J.-F. Kapp, M. Steinmayr, St. Stuerzebecher, Horowski, R., Kapp, J.-F., Steinmayr, M., Stuerzebecher, St.